Byter-AL Tablet
Marketer
Positif Life sciences
Salt Composition
Artemether (80mg) + Lumefantrine (480mg)
Overview Byter-AL Tablet
Malarone-AL tablets effectively combat malaria in patients of all ages. This combination therapy utilizes two antimalarial drugs to eliminate the malaria parasite, thus halting infection progression. It's crucial to understand that Malarone-AL is for treating existing malaria, not for prevention or severe cases impacting vital organs like the brain, lungs, or kidneys. Optimal absorption requires ingestion with food. Always adhere to your physician's prescribed dosage and duration; exceeding the recommended amount can be detrimental. Complete the entire course to ensure complete parasite eradication. Common, albeit usually mild, side effects may include headache, reduced appetite, fatigue, arthralgia, and myalgia; dizziness is also possible. Report any persistent or worsening side effects to your doctor. Prior to commencing treatment, disclose all other medications you are currently using to your doctor. Use during pregnancy or breastfeeding is strictly contraindicated unless explicitly approved by your healthcare provider due to potential harm to the fetus or infant.
Uses of Byter-AL Tablet
Managing Malaria Infections
Major Benefits of Byter-AL Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Byter-AL Tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with food.
Common Side effects of Byter-AL Tablet:
- Headache
- Loss of appetite
- Dizziness
- Weakness
- Joint pain
- Muscle pain
How to use Byter-AL Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Byter-AL Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with food.
How Byter-AL Tablet works:
Artemether and Lumefantrine, the active components of Byter-AL Tablets, combat malaria through a synergistic antiparasitic action. The medication elevates blood haem levels, a substance harmful to the malaria parasite, thereby eliminating the parasite and halting disease progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Byter-AL Tablet has unknown safety implications. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Byter-AL Tablets during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks before prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
The use of Byter-AL Tablets while breastfeeding appears to pose minimal risk. Available human data indicate insignificant danger to the infant.
DrivingUNSAFE
Alertness, vision, and coordination may be impaired by Byter-AL Tablets, potentially causing drowsiness and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Individuals with severe kidney impairment should exercise caution when using Byter-AL Tablets. Dosage modification may be necessary; physician consultation is advised. Severe kidney disease does not necessitate a dosage change.
LiverCAUTION
Exercise caution when administering Byter-AL Tablets to individuals with advanced hepatic impairment. Dosage modification for Byter-AL Tablets might be necessary; physician consultation is advised. Severe hepatic impairment does not necessitate a dosage alteration.
What if you forget to take Byter-AL Tablet :
Should you forget a Byter-AL Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Byter-AL Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimalarial Medications |
3,018 People bought this recently